Cancer
Recent research at the First Hospital of Hunan University of Chinese Medicine has shed new light on the potential of metal nanoparticles in cancer diagnosis and treatment. The study, published in the journal Drug Delivery, revealed that metal nanoparticles (MNPs) have unique physicochemical properties that enable precise drug delivery and
Cancer
Researchers at Amity University Uttar Pradesh have highlighted the critical role of membrane transporters in cancer, noting that their expression is frequently reprogrammed to support enhanced growth, survival, and therapy resistance. These transporters, regulated by the tumor suppressor p53, facilitate the uptake and efflux of nutrients, ions, and drugs, making
Cancer
Researchers at Sichuan Cancer Hospital have developed covalent organic frameworks (COFs) that can be tailored for use in cancer treatment and drug delivery. COFs are crystalline and porous materials formed from organic molecules that can have their mechanical properties adjusted to suit various applications. This review summarizes the strategies for
Chemotherapy
Researchers at Tongji University School of Medicine in Shanghai, People's Republic of China, have made a significant breakthrough in the treatment of colorectal cancer (CRC) by harnessing the symbiotic relationship between bacteria and CRC. The study, published in the Journal of Controlled Release, reveals that engineered tumor-symbiotic bacterial
Cancer
Researchers at Sichuan Cancer Hospital have developed covalent organic frameworks (COFs) that can be tailored for use in cancer treatment and drug delivery. COFs are crystalline and porous materials formed from organic molecules that can have their mechanical properties adjusted to suit various applications. This review summarizes the strategies for
Asian medicine
Researchers at Nanjing University of Chinese Medicine have made a significant breakthrough in the treatment of liver cancer using a novel delivery system. The Astragaloside II (ASII)-loaded neutrophil nanocarrier system, known as PG@AS-Neu, has been shown to exhibit potent anticancer effects while maintaining the integrity of the cancer-fighting
Diseases
A breakthrough in the treatment of alcoholic liver disease (ALD) has been achieved by Dalian Polytechnic University researchers, who have designed a novel galactosamine-modified probiotic vesicle delivery strategy to overcome drug penetration barriers in ALD. This innovative approach collaborates with fucoxanthin (FX)-mediated lipid-lowering therapy to improve alcohol-induced lipid metabolism
Nanotechnology
Researchers at Kocaeli University in Turkey have discovered that nanoparticles containing growth factors can effectively differentiate neural stem cells into dopaminergic neurons in vitro, offering potential therapeutic strategies for Parkinson's disease management. The team, led by Yusufhan Yazir, used poly(lactic-co-glycolic acid) nanoparticles (PLGA-NPs) loaded with Brain-Derived Neurotrophic
Nanotechnology
Researchers from the University of Munster have made significant advancements in the development of pH-responsive nanoparticles for controlled and selective drug release. These nanocarriers have the potential to revolutionize cancer therapy by exploiting cancer cells' acidic environment for targeted substance release. The study employed a combination of polymer design
Nanotechnology
Investigators at Saveetha Medical College and Hospital in Tamil Nadu, India, have made significant strides in developing tumor-targeted polymeric nanoparticles for the treatment of head and neck cancer (HNC). According to a recent review, these nanoparticles have emerged as a promising strategy to improve therapeutic efficacy while minimizing adverse effects.
Nanotechnology
Researchers at Yunnan University of Chinese Medicine have made a significant breakthrough in the development of nanocarriers for drug delivery. According to the study, surface modification of nanocarriers with ligands such as sugars, peptides, and small-molecule compounds enhances their functional properties, allowing for targeted delivery of drugs to specific organs,
Nanotechnology
Researchers from the University of Virginia have made significant strides in understanding the self-assembly of nanoparticles, particularly in the context of designing amphiphilic surfaces. By leveraging the properties of dodecanethiol and 2-ethoxyethane-1-thiol, the team has developed a framework for predicting and controlling the local ordering of surface ligands on ultrasmall
